BioMarin Pharmaceutical, Inc. (BMRN)
54.11
-1.16
(-2.10%)
USD |
NASDAQ |
Apr 16, 16:00
54.65
+0.54
(+1.00%)
After-Hours: 17:11
BioMarin Pharmaceutical Cash from Investing (Quarterly) : -42.45M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -6.494M |
| Ionis Pharmaceuticals, Inc. | -419.50M |
| Mirum Pharmaceuticals, Inc. | 1.006M |
| Hims & Hers Health, Inc. | -83.68M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 99.64M |
| Cash from Financing (Quarterly) | 3.157M |
| Free Cash Flow | 717.02M |
| Free Cash Flow Per Share (Quarterly) | 0.2942 |
| Free Cash Flow to Equity (Quarterly) | 24.87M |
| Free Cash Flow to Firm (Quarterly) | 61.32M |
| Free Cash Flow Yield | 6.81% |